Results 241 to 250 of about 472,906 (286)

Assessing Risk Thresholds in Controlled Human Infection Models (CHIM)

open access: yesBioethics, EarlyView.
ABSTRACT Controlled Human Infection Models (CHIMs) are a type of clinical trial involving deliberately exposing human volunteers to an infectious agent. Compared to studies of natural infection, CHIMs offers distinctive benefits, from the ability to study presymptomatic infection to a direct assessment of the efficacy of vaccines and therapeutics in a ...
Alexa Nord‐Bronzyk   +4 more
wiley   +1 more source

Laboratory diagnostics and follow-up of medullary thyroid cancer. [PDF]

open access: yesJ Mol Endocrinol
Giovanella L   +3 more
europepmc   +1 more source

Beyond Sporting Talent: Other Determinants of Football Clubs’ Wage Bills

open access: yesBulletin of Economic Research, EarlyView.
ABSTRACT This article delves into the understanding of how football clubs determine wage bills to compensate talent. Using data from first‐division teams in elite European leagues, we estimate wage models based on indicators of sporting performance, “Elo ratings” as a proxy for clubs’ historical achievements and brand strength, and “media visibility ...
Alice Aguiar‐Noury   +1 more
wiley   +1 more source

Mapping cellular vulnerability in Parkinson's disease using retro-AAVs and preformed α-synuclein fibrils. [PDF]

open access: yesTransl Neurodegener
Geibl FF   +12 more
europepmc   +1 more source

Psilocybin as a novel treatment for chronic pain

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey   +3 more
wiley   +1 more source

Author Correction: Operando microimaging of crystal structure and orientation in all components of all-solid-state-batteries. [PDF]

open access: yesNat Commun
Jacquet Q   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy